TVGN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tevogen Bio Holdings Inc (TVGN) is not a good buy for a beginner, long-term investor at this time. The stock is currently in a bearish trend, with significant negative price momentum, insider selling, and weak financials. Additionally, the recent reverse stock split and lack of positive trading signals suggest further downside risk in the near term.
The stock is in a bearish trend with MACD negatively expanding (-0.573), RSI at 8.448 indicating oversold conditions, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The current price of $7.08 is below key support levels, with S1 at 7.769 and S2 at 5.751.
Tevogen is exploring a potential acquisition of Apozeal Pharmaceuticals, which could enhance its generics platform with 11 FDA-approved products.
The company recently executed a 1-for-50 reverse stock split to comply with Nasdaq's minimum bid requirements, which is typically perceived negatively by the market. Insiders have increased selling by 140.46% over the last month, and hedge funds remain neutral. Analysts have downgraded the stock to Hold, citing near-term trading pressure and a weaker capital markets position.
In Q3 2025, the company reported zero revenue growth (0.00% YoY), a net income decline to -$5,862,428 (-0.80% YoY), and no improvement in gross margin or EPS. The financials indicate no significant growth trends.
D. Boral Capital downgraded the stock to Hold from Buy, citing the reverse stock split and its potential to add near-term trading pressure. No price target was provided.
